Sold 260-300 and bought back 200-160. MDGL has their PDUFA meeting with the FDA on March 14th for approval. If something delays approval like a label issue and the stock crashes, buy the stock. Low chance it doesn't get approved eventually even with potential road blocksGot lucky on my MDGL buy yesterday. It's up $9 a share already
Their trials are at least a year ahead of VKTX and they report phase 3 NASH data by the end of this year, and there currently aren't any good FDA approved NASH treatments
Will go up a ton on good data
Since this post MDGL is 238 now from 73
VKTX is 15.50 now from 4
These fatty liver drugs will be big money once FDA approved
I wonder if Bitcoin will reach 50K by the end of the week.